The drugmaker said the results for giredestrant open the door to adding a treatment option at an early stage of the cancer, ...

“Our data shows that as many as 20% of breast cancer survivors on aromatase inhibitors will stop taking their medication ...

Adam Brufsky, MD, PhD, addresses how the COVID-19 pandemic affected breast cancer screening rates across Pittsburgh.

Radiation therapy plays a vital role in breast cancer treatment. Get clear information on how it works, its benefits, and how ...

Roche's ROG.S experimental oral drug giredestrant has been shown to cut the risk of recurrence of a common form of breast ...

A real-world analysis of more than 60,000 patients in the US finds median survival increased by almost 7 months from 2011 to ...

WeGotThis.org founder and author Elissa Kalver wants to reframe the conversation around metastatic breast cancer.

Women with breast cancer and preexisting atopic/allergic conditions faced a heightened risk for radiodermatitis up to 36 ...

A nursing professor dispels common myths, explains the risks, and highlights promising new treatments. Breast cancer is one of the most commonly diagnosed cancers in the world and remains a major ...

The Equal Employment Opportunity Commission filed suit November 17 against Penney OpCo LLC, claiming the retailer's leave ...

Breast Cancer Canada has released its 2025 Annual Progress Report, offering a comprehensive overview of breast cancer care in Canada. The report highlights advances in treatment, screening, and policy ...

One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime. For many, the diagnosis doesn’t end ...